Mark V. Anquillare
CIK: 0001472710
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (7 total)
- Aug 3, 2026TDOC
Teladoc Health, Inc.
Award(A)DirectRestricted Stock Units
37.4K shares- - Jul 9, 2026TBRG
TruBridge, Inc.
Disposition(D)Direct21.6K shares at avg. $26.25$566K - Dec 15, 2025GWRE
Guidewire Software, Inc.
Award(A)Direct1.2K shares- - Mar 13, 2025TBRG
TruBridge, Inc.
Award(A)Direct4.4K shares- - Dec 17, 2024GWRE
Guidewire Software, Inc.
Award(A)Direct1.2K shares- - Nov 25, 2024TBRG
TruBridge, Inc.
Purchase(P)Direct2.5K shares at avg. $16.81$42K - Sep 23, 2024GWRE
Guidewire Software, Inc.
Award(A)Direct309 shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Aug 3, 2026 |  TDOC Teladoc Health, Inc. | Award(A) Restricted Stock Units | 37,425 | - | - | Direct |
| Jul 9, 2026 |  TBRG TruBridge, Inc. | Disposition(D) | 21,554 | $26.25 | $565,793 | Direct |
| Dec 15, 2025 |  GWRE Guidewire Software, Inc. | Award(A) | 1,196 | - | - | Direct |
| Mar 13, 2025 | TBRG TruBridge, Inc. | Award(A) | 4,376 | - | - | Direct |
| Dec 17, 2024 | GWRE Guidewire Software, Inc. | Award(A) | 1,211 | - | $0 | Direct |
| Nov 25, 2024 | TBRG TruBridge, Inc. | Purchase(P) | 2,500 | $16.81 | $42,025 | Direct |
| Sep 23, 2024 | GWRE Guidewire Software, Inc. | Award(A) | 309 | - | $0 | Direct |
1-7 of 7 transactions
About Anquillare Mark V
Anquillare Mark V (SEC CIK 0001472710) files insider reports with the SEC as Director of Teladoc Health, Inc. (TDOC), Director of TruBridge, Inc. (TBRG) and Director of Guidewire Software, Inc. (GWRE).
Signal8 holds 9 ownership filings by Anquillare Mark V (2 Form 3, 7 Form 4), filed between Sep 25, 2024 and Aug 4, 2026. Those filings report 7 transactions, from Sep 23, 2024 to Aug 3, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Anquillare Mark V's filings is in NEW YORK, NY.
Recent filings by Anquillare Mark V
- Aug 3, 2026: Grant or award of TDOC derivative securities (Form 4, code A).
- Jul 9, 2026: Disposition to issuer transaction of TBRG shares (Form 4, code D).
- Dec 15, 2025: Grant or award of GWRE shares (Form 4, code A).
- Mar 13, 2025: Grant or award of TBRG shares (Form 4, code A).
- Dec 17, 2024: Grant or award of GWRE shares (Form 4, code A).
Other insiders filing for Teladoc Health, Inc. (TDOC)
- Catapano Joseph Ronald, Chief Accounting Officer
- DIVITA CHARLES III, CHIEF EXECUTIVE OFFICER
- Nueno Carlos, President, International
- Vandervoort Adam C, CHIEF LEGAL OFFICER, SECRETARY
- Bliss Kelly, President, U.S. Group Health
- Rodrigues Fernando M., President of BetterHelp